IP Library Granted Patent US 8,209,006
Granted Patent B2
US 8,209,006 · App. 10/657,725 · Granted Jun 26, 2012

Constant current electroporation device and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,209,006
App. No.
10/657,725
Granted
Jun 26, 2012
Kind
B2
Abstract

An electroporation device which may be used to effectively facilitate the introduction of a macromolecule into cells of a selected tissue in a body or plant. The electroporation device comprises an electro-kinetic device (“EKD”) whose operation is specified by software or firmware. The EKD produces a series of programmable constant-current pulse patterns between electrodes in an array based on user control and input of the pulse parameters and allows the storage and acquisition of current waveform data. The electroporation device also comprises a replaceable electrode disk having an array of needle electrodes, a central injection channel for an injection needle, and a removable guide disk.

Claims (47)

1. An electroporation device comprising:

a support structure that includes a sterile injection channel adapted to receive a syringe needle;

an electrode assembly having a plurality of needle electrodes for penetrating a selected tissue and delivering an electrical pulse, wherein the needle electrodes are mounted in an array around the sterile injection channel of the support structure;

a current waveform generator in electrical communication with the plurality of needle electrodes, the waveform generator being capable of generating the electrical pulse;

a power source in electrical communication with the current waveform generator;

a controller in communication with the current waveform generator and the power source; and

a waveform logger in communication with the controller;

wherein the controller is capable of managing the electroporation device to expose tissue adjacent to the needle electrodes to a substantially constant current independent of any resistance change in the selected tissue during the electrical pulse, the controller is capable of sampling and monitoring the electroporation voltage and current waveforms, and the waveform logger is capable of recording the electroporation voltage and current waveforms.

2. The device of claim 1 , further comprising an impedance tester in electrical communication with the plurality of needle electrodes.

3. The device of claim 1 , further comprising an input device for inputting commands into the controller.

4. The device of claim 3 , wherein the input device is a keypad.

5. The device of claim 1 , further comprising a status-reporting device for reporting status information during the electroporation procedure.

6. The device of claim 5 , wherein the status-reporting device is an information display panel, an audible notification, a light-emitting diode (“LED”), or a combination thereof.

7. The device of claim 1 , further comprising a communications port in communication with the controller.

8. The device of claim 7 , wherein the communications port is an optical serial communications port.

9. The device of claim 7 , wherein the communications port is an infrared port.

10. The device of claim 1 , further comprising memory in communication with the controller.

11. The device of claim 10 , wherein the memory is non-volatile.

12. The device of claim 1 , wherein the power source is a battery.

13. The device of claim 1 , wherein the electrode assembly further comprises a handle to which the support structure is connected to, and further wherein the sterile injection channel extends through the handle.

14. The device of claim 13 , wherein the electrode assembly further comprises an activation switch mounted on the handle and in communication with the controller.

15. The device of claim 1 , wherein the array is a circular array.

16. The device of claim 15 , wherein the circular array is about 1.0 cm in diameter.

17. A method for electroporating cells of a selected tissue to facilitate the introduction of macromolecules, comprising:

programming an electrical pulse pattern into a controller of an electroporation device, wherein the electroporation device comprises:

an electrode assembly having a plurality of needle electrodes for penetrating a selected tissue and delivering an electrical pulse, wherein the needle electrodes are mounted in an array around a sterile injection channel of a support structure;

a current waveform generator in electrical communication with the plurality of needle electrodes, the waveform generator being capable of generating the electrical pulse;

a power source in electrical communication with the current waveform generator;

a controller in communication with the current waveform generator and the power source; and

a waveform logger in communication with the controller;

wherein the controller is capable of managing the electroporation device to expose the selected tissue to a substantially constant current independent of any resistance change in the selected tissue during the electrical pulse, the controller is capable of sampling and monitoring the electroporation voltage and current waveforms, and the waveform logger is capable of recording the electroporation voltage and current waveforms;

inserting the plurality of needle electrodes of the electrode assembly into the selected tissue;

measuring the resistance of the plurality of needle electrodes to determine if a circuit can safely be established through the selected tissue;

injecting a solution of the macromolecules into the selected tissue by passing a syringe needle through the sterile injection channel;

generating a pulse of electrical energy from the waveform generator in accordance with the programmed electrical pulse pattern; and

applying the pulse of electrical energy to the plurality of needle electrodes in accordance with the programmed electrical pulse pattern for a time and under conditions effective to expose the selected tissue to a substantially constant electrical current.

18. The method of claim 17 , further comprising electronically recording data related to the electroporation through a waveform logger in communication with the controller.

19. An electroporation device comprising:

an electrode assembly having a support structure including a sterile injection channel, and an electrode disk comprising a plurality of needle electrodes for penetrating a selected tissue and delivering an electrical pulse, wherein the needle electrodes are mounted in an array around the sterile injection channel and the sterile injection channel is adapted to receive a syringe needle;

a current waveform generator in electrical communication with the plurality of needle electrodes, the waveform generator being capable of generating the electrical pulse;

a power source in electrical communication with the current waveform generator;

a controller in communication with the current waveform generator and the power source, wherein the controller is comprised of firmware;

and

a waveform logger in communication with the controller;

wherein the controller is capable of sampling and monitoring the electroporation voltage and current waveforms, and the waveform logger is capable of recording the electroporation voltage and current waveforms, and the firmware is capable of managing the waveforms generated by the waveform generator to expose tissue adjacent to the needle electrodes to a substantially constant current independent of any resistance change in the selected tissue during the electrical pulse.

20. The electroporation device of claim 19 , wherein the electrode disk is a replaceable disk.

21. The electroporation device of claim 19 , wherein the array is a circular array.

Assignments (9)
MERGER Recorded Feb 2, 2021
From: VGX PHARMACEUTICALS, LLC
To: INOVIO PHARMACEUTICALS, INC.
Reel/Frame 055114/0843 →
MERGER AND CHANGE OF NAME Recorded Dec 21, 2020
From: VGX PHARMACEUTICALS, INC.; INOVIO ACQUISITION, LLC
To: VGX PHARMACEUTICALS, LLC
Reel/Frame 054704/0830 →
MERGER Recorded Aug 1, 2007
From: ADVISYS INC.
To: VGX PHARMACEUTICALS, INC.
Reel/Frame 019628/0144 →
RELEASE OF SECURITY INTEREST Recorded Feb 20, 2007
From: BERGAN, RONALD
To: ADVISYS, INC.
Reel/Frame 018907/0249 →
ASSIGNMENT OF PROMISSORY NOTES AND WARRANTS Recorded Nov 29, 2006
From: MCMINN, WILLIAM A.
To: BERGAN, RONALD
Reel/Frame 018552/0637 →
ASSIGNMENT OF PROMISSORY NOTES AND WARRANTS Recorded Nov 29, 2006
From: CAIN, ESTATE OF GORDON A.
To: BERGAN, RONALD
Reel/Frame 018552/0597 →
ASSIGNMENT OF PROMISSORY NOTES AND WARRENTS Recorded Nov 29, 2006
From: BAYLOR COLLEGE OF MEDICINE
To: BERGAN, RONALD
Reel/Frame 018552/0654 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2004
From: SMITH, LOUIS C.; DRAGHIA-AKLI, RUXANDRA; KHAN, AMIR S.; CARPENTER, ROBERT H.; DARNELL, JEFF
To: ADVISYS, INC.
Reel/Frame 015006/0010 →
SECURITY AGREEMENT Recorded Jan 14, 2004
From: ADVISYS INC.
To: ESTATE OF GORDAN A. CAIN
Reel/Frame 014250/0979 →